163 related articles for article (PubMed ID: 26045292)
21. Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia.
Li MJ; Yang YL; Lee NC; Jou ST; Lu MY; Chang HH; Lin KH; Peng CT; Lin DT
J Formos Med Assoc; 2016 Sep; 115(9):801-6. PubMed ID: 26414667
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.
Zidan MA; Kamal Shaaban HM; Elghannam DM
Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521
[TBL] [Abstract][Full Text] [Related]
23. Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.
Becker H; Maharry K; Mrózek K; Volinia S; Eisfeld AK; Radmacher MD; Kohlschmidt J; Metzeler KH; Schwind S; Whitman SP; Mendler JH; Wu YZ; Nicolet D; Paschka P; Powell BL; Carter TH; Wetzler M; Kolitz JE; Carroll AJ; Baer MR; Caligiuri MA; Stone RM; Marcucci G; Bloomfield CD
Leukemia; 2014 Aug; 28(8):1754-1758. PubMed ID: 24651097
[No Abstract] [Full Text] [Related]
24. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
[TBL] [Abstract][Full Text] [Related]
25. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms.
Scopim-Ribeiro R; Machado-Neto JA; de Melo Campos P; Niemann FS; Lorand-Metze I; Costa FF; Olalla Saad ST; Traina F
Diagn Pathol; 2016 Mar; 11():28. PubMed ID: 26984174
[TBL] [Abstract][Full Text] [Related]
26. TET2 mutations in childhood leukemia.
Langemeijer SM; Jansen JH; Hooijer J; van Hoogen P; Stevens-Linders E; Massop M; Waanders E; van Reijmersdal SV; Stevens-Kroef MJ; Zwaan CM; van den Heuvel-Eibrink MM; Sonneveld E; Hoogerbrugge PM; van Kessel AG; Kuiper RP
Leukemia; 2011 Jan; 25(1):189-92. PubMed ID: 21042320
[No Abstract] [Full Text] [Related]
27. Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia.
Wang J; He N; Wang R; Tian T; Han F; Zhong C; Zhang C; Hua M; Ji C; Ma D
Sci Rep; 2020 Feb; 10(1):2706. PubMed ID: 32066746
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of TET2 gene expression in 157 adult acute myeloid leukemia patients with normal cytogenetics].
Zhu Z; Chen J; Yu M; Chen F; Chen Z; Lou J; Tong H; Huang J; Qian W; Meng H; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):802-7. PubMed ID: 25246247
[TBL] [Abstract][Full Text] [Related]
29. Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms.
Venton G; Courtier F; Charbonnier A; D'incan E; Saillard C; Mohty B; Mozziconacci MJ; Birnbaum D; Murati A; Vey N; Rey J
Am J Hematol; 2018 Mar; 93(3):330-338. PubMed ID: 29148089
[TBL] [Abstract][Full Text] [Related]
30. [Mutations in TET2 in myeloid cancers].
Bernard OA; Delhommeau F; Fontenay M; Vainchenker W
Med Sci (Paris); 2009 Oct; 25(10):785-8. PubMed ID: 19849974
[No Abstract] [Full Text] [Related]
31. Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.
Couronné L; Lippert E; Andrieux J; Kosmider O; Radford-Weiss I; Penther D; Dastugue N; Mugneret F; Lafage M; Gachard N; Nadal N; Bernard OA; Nguyen-Khac F
Leukemia; 2010 Jan; 24(1):201-3. PubMed ID: 19710701
[No Abstract] [Full Text] [Related]
32. [Analysis of the Effect of TET2 Mutation and SNP on Clinical Characteristics and Prognosis of AML Patients].
Li L; An LC; Chu XX; Liu XQ; Wang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):453-459. PubMed ID: 32319378
[TBL] [Abstract][Full Text] [Related]
33. Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1.
Das AB; Kakadia PM; Wojcik D; Pemberton L; Browett PJ; Bohlander SK; Vissers MCM
Blood Cancer J; 2019 Oct; 9(10):82. PubMed ID: 31578317
[No Abstract] [Full Text] [Related]
34. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.
Yamazaki J; Taby R; Jelinek J; Raynal NJ; Cesaroni M; Pierce SA; Kornblau SM; Bueso-Ramos CE; Ravandi F; Kantarjian HM; Issa JP
J Natl Cancer Inst; 2015 Nov; 108(2):. PubMed ID: 26568194
[TBL] [Abstract][Full Text] [Related]
35. Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy.
Kern W; Haferlach T; Schnittger S; Ludwig WD; Hiddemann W; Schoch C
Leukemia; 2002 Oct; 16(10):2084-91. PubMed ID: 12357361
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.
Euba B; Vizmanos JL; García-Granero M; Aranaz P; Hurtado C; Migueliz I; Novo FJ; García-Delgado M
Leuk Lymphoma; 2012 Jun; 53(6):1230-3. PubMed ID: 22080757
[No Abstract] [Full Text] [Related]
37. Familial myeloid malignancies with germline TET2 mutation.
Duployez N; Goursaud L; Fenwarth L; Bories C; Marceau-Renaut A; Boyer T; Fournier E; Nibourel O; Roche-Lestienne C; Huet G; Beauvais D; Berthon C; Cambier N; Quesnel B; Preudhomme C
Leukemia; 2020 May; 34(5):1450-1453. PubMed ID: 31827242
[No Abstract] [Full Text] [Related]
38. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ahn JS; Kim JY; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Jan; 95(2):301-10. PubMed ID: 26537612
[TBL] [Abstract][Full Text] [Related]
39. Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics.
Cagnetta A; Adamia S; Acharya C; Patrone F; Miglino M; Nencioni A; Gobbi M; Cea M
Leuk Res; 2014 Jun; 38(6):649-59. PubMed ID: 24726781
[TBL] [Abstract][Full Text] [Related]
40. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
